Ningbo Tianlong Electronics Co., Ltd. completed the acquisition of 4.1818% stake in Wuhan First Bioscience Inc. from Boai NKY Medical Holdings Ltd..
March 01, 2021
Share
Ningbo Tianlong Electronics Co., Ltd. (SHSE:603266) entered into a equity transfer agreement to acquire 4.1818% stake in Wuhan First Bioscience Inc. from Boai NKY Medical Holdings Ltd. (SZSE:300109) for CNY 14 million on January 6, 2021. Ningbo Tianlong Electronics will pay the total consideration to Boai NKY Medical Holdings within 5 working days after the agreement becomes effective. As a result of the transaction, Boai NKY Medical Holdings Ltd. will hold 4% stake in Wuhan First Bioscience Inc. The transaction was approved by the Board of Directors of Boai NKY Medical Holdings Ltd.
Ningbo Tianlong Electronics Co., Ltd. (SHSE:603266) completed the acquisition of 4.1818% stake in Wuhan First Bioscience Inc. from Boai NKY Medical Holdings Ltd. (SZSE:300109) on March 2, 2021. Board of Directors of Boai NKY Medical Holdings Ltd. approved to use own funds of CNY 14 million for the transaction.
Ningbo Tianlong Electronics Co., Ltd. is a China-based company and mainly engaged in manufacture and sales of precise plastic parts. In terms of motor vehicles precision plastic parts, the products of the company are functional plastic parts. In terms of plastic parts for electrical appliances, companyâs main products include circuit breaker panels, programmable logic controllers and structures, and among others. In terms of plastic parts of consumer electronics, companyâs main products includes printer stents, gears, mobile phone models, mobile phone shells, mobile phone protection shell casings, camera shells, and among others. The Companyâs products are applied in automotive, electrical appliances, consumer electronics, medical equipments, aviation and other areas of plastic parts production. The Company operates its businesses primary in domestic market.
NINGBO TIANLONG ELECTRONICS CO., LTD. 
